Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phasorz Technologies is the Indian digital health company behind the MediBuddy platform and the legacy DocsApp brand. The company operates a consumer and enterprise healthcare platform offering online doctor consultations, diagnostics and lab-test booking, medicine ordering, health checkups, and related outpatient, inpatient, and wellness services. It appears to be an active private company rather than a therapeutics developer, so it does not have a conventional drug pipeline, molecular targets, or clinical-stage asset portfolio. Its business is centered on healthcare access, care navigation, and technology-enabled service delivery across patients, providers, employers, insurers, and healthcare partners. For biotech analysts, the closest fit is a commercial-stage digital health services and telemedicine platform rather than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phasorz Technologies.